Two Sigma Securities’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-4
| Closed | -$2.67K | – | 2219 |
|
2023
Q3 | $2.67K | Sell |
4
-4
| -50% | -$2.67K | ﹤0.01% | 1280 |
|
2023
Q2 | $37.4K | Buy |
+8
| New | +$37.4K | ﹤0.01% | 919 |
|
2020
Q4 | – | Sell |
-7
| Closed | -$24K | – | 1192 |
|
2020
Q3 | $24K | Buy |
+7
| New | +$24K | ﹤0.01% | 447 |
|
2020
Q2 | – | Sell |
-7
| Closed | -$14K | – | 1139 |
|
2020
Q1 | $14K | Buy |
7
+3
| +75% | +$6K | ﹤0.01% | 560 |
|
2019
Q4 | $18K | Sell |
4
-2
| -33% | -$9K | ﹤0.01% | 725 |
|
2019
Q3 | $21K | Buy |
+6
| New | +$21K | ﹤0.01% | 668 |
|
2017
Q3 | – | Hold |
0
| – | -$18K | – | 1242 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 787 |
|
2016
Q2 | – | Hold |
0
| – | -$19K | – | 542 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 241 |
|